InsiderSignal.AI

InsiderSignal.ai

BCYC - Bicycle Therapeutics Plc

Insider Sale by Lee Kevin (CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Lee Kevin, serving as CEO at Bicycle Therapeutics Plc (BCYC), sold 7,683 shares at $4.94 per share, for a total transaction value of $37,964.00. Following this transaction, Lee Kevin now holds 611,313 shares of BCYC.

This sale represents a 1.00% decrease in Lee Kevin's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 4 days after the trade was made.

Bicycle Therapeutics Plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Lee Kevin

CEO

Kevin Lee, Ph.D., MBA, is the Chief Executive Officer and Executive Director of Bicycle Therapeutics plc (BCYC), a biotechnology company developing bicyclic peptide-based therapeutics, particularly Bicycle Drug Conjugates (BDCs) for oncology.[[1]](https://fintool.com/app/research/companies/BCYC/people/kevin-lee)[[2]](https://www.fiercebiotech.com/biotech/bicycle-therapeutics-announces-appointment-of-dr-kevin-lee-as-chief-executive-officer)[[7]](https://www.bicycletherapeutics.com/profile/leadership/) He has served in this role since September 2015, overseeing clinical strategy, financing—including a $555 million private placement in May 2024 extending the runway into 2H27—and pipeline advancements like zelenectide pevedotin showing 45% ORR in metastatic urothelial cancer.[[1]](https://fintool.com/app/research/companies/BCYC/people/kevin-lee)[[6]](https://www.businessweekly.co.uk/posts/bicycle-therapeutics-set-for-transformational-2025-says-ceo) In 2025, Lee received the Entrepreneur of the Year award from the BioIndustry Association for his leadership in pioneering precision therapeutics.[[3]](https://www.bioindustry.org/resource/kevin-lee-ceo-of-bicycle-therapeutics-wins-entrepreneur-of-the-year-at-the-2025-bia-gala-dinner.html) Prior to Bicycle Therapeutics, Lee was Senior Vice President and Chief Scientific Officer of Pfizer's Rare Disease Research Unit (2012–2015), where he managed over 20 R&D programs, established the rare disease strategy, created the Genetic Medicine Institute, and founded the Rare Disease Research Consortium.[[1]](https://fintool.com/app/research/companies/BCYC/people/kevin-lee)[[2]](https://www.fiercebiotech.com/biotech/bicycle-therapeutics-announces-appointment-of-dr-kevin-lee-as-chief-executive-officer)[[5]](https://www.alchemab.com/team-member/kevin-lee-phd-mba/) Earlier, he held senior R&D roles at GlaxoSmithKline (GSK), leading epigenetics research and forming strategic partnerships, and founded Cambridge Biotechnology Ltd. (sold in 2005) and Neurosolutions (now Oncosil Medical).[[1]](https://fintool.com/app/research/companies/BCYC/people/kevin-lee) A pharmacologist by training with a long-standing interest in novel technologies, genetics, oncology, and rare diseases, Lee has driven major deals like a €1B partnership with AstraZeneca.[[4]](https://www.labiotech.eu/interview/bicycle-therapeutics-kevin-lee-interview/)

View full insider profile →

Trade Price

$4.94

Quantity

7,683

Total Value

$37,964.00

Shares Owned

611,313

Trade Date

Thursday, April 2, 2026

7 days ago

SEC Filing Date

Monday, April 6, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Bicycle Therapeutics Plc

Company Overview

No company information available
View news mentioning BCYC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5422951

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime